Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus for Atopic Dermatitis in African American Children
NCT00810862Phase 4Terminated
- Sponsor
- Children's Hospital of Michigan
- Start
- Nov 2006
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of pimecrolimus in atopic dermatitis (AD), sponsored by Children's Hospital of Michigan. Started Nov 2006; status: terminated.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00810862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810862.